Prolia Pricing: A High Bar For Osteoporosis But Room To Tap Oncology Potential

With a wholesale acquisition cost of $1,650 a year for Prolia, Amgen has effectively sacrificed the first-line treatment market for osteoporosis in favor of long-term potential in future indications.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet